appreciate
miller
contribution
debate
whether
one
us
phrase
established
treatment
proven
therapy
urge
caution
using
litmus
test
decide
whether
use
placebo
acceptable
term
beg
defined
carefully
nonsteroidal
drug
considered
proven
arthritis
despite
problem
assay
sensitivity
miller
state
established
treatment
adenomatous
polyp
however
evidence
epidemiological
study
clinical
trial
supporting
use
aspirin
nonsteroidal
drug
condition
armed
qualifies
aspirin
proven
therapy
open
subjective
placebo
opponent
maintain
would
argue
design
ethical
alternative
design
actually
used
approve
miller
focus
question
defending
use
placebo
approve
study
focus
reflects
prevailing
bias
choose
acceptable
use
placebo
rather
choose
acceptable
omit
placebo
bias
evident
current
version
declaration
helsinki
wording
extreme
care
must
taken
making
use
trial
thus
use
placebo
typically
presumed
guilty
proven
innocent
design
presumed
innocent
proven
guilty
declaration
silent
possibility
omitting
placebo
lead
problem
witnessed
vioxx
perhaps
important
question
whether
defensible
exclude
placebo
vigor
study
miller
acknowledges
placebo
would
provided
better
assessment
safety
signal
vigor
study
indeed
placebo
used
author
able
plausibly
conclude
difference
two
group
due
naproxen
causing
benefit
rather
vioxx
causing
harm
plausibility
conclusion
since
questioned
misleading
safety
signal
delayed
withdrawal
vioxx
design
superficially
ethical
science
advanced
public
health
one
might
protest
comment
made
benefit
hindsight
true
medical
community
large
become
aware
safety
issue
september
result
approve
study
made
public
vioxx
withdrawn
however
according
david
graham
testimony
united
state
senate
report
internal
merck
document
good
reason
concern
possible
safety
signal
vioxx
approved
recruitment
vigor
began
vigor
study
included
placebo
arm
truth
vioxx
could
learned
february
instead
september
week
infamous
two
four
jumbo
jetliner
allowed
continue
dropping
sky
every
week
using
midpoint
graham
range
estimate
work
excess
heart
attack
stroke
including
death
alone
author
vigor
study
said
could
include
placebo
group
idea
including
placebo
arm
suggested
rejected
unethical
even
though
rescue
medication
could
used
take
path
least
resistance
interest
rapid
institutional
review
board
approval
ease
patient
recruiting
whatever
reason
decision
omit
placebo
led
ambiguity
inaction
clinical
trial
whether
one
look
efficacy
please
see
opening
argument
debate
safety
omitting
placebo
often
muddies
scientific
water
place
public
health
increased
risk
good
science
good
ethic
divorced
one
another
believe
consideration
factor
discussion
ethic
clinical
trial
design
experience
another
vioxx
hope
future
version
declaration
helsinki
add
extreme
care
must
taken
omitting
placebo
